Bone demineralization in adult thalassaemic patients: Contribution of GH and IGF-I at different skeletal sites

Clinical Endocrinology

Volumn 69, Issue 2, 2008, Pages 202-207

  Scacchi, Massimo ^a   Danesi, Leila ^a   Cattaneo, Agnese ^a   Valassi, Elena ^a   Giraldi, Francesca Pecori ^a   Argento, Crocetta ^b   D'Angelo, Emanuela ^a   Mirra, Nadia ^a   Carnelli, Vittorio ^a   Zanaboni, Laura ^a   Tampieri, Benedetta ^a   Cappellini, Maria Domenica ^a   Cavagnini, Francesco ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Azienda Ospedaliera San Giovanni di Dio   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; SOMATOMEDIN C;

ADULT; ARTICLE; BETA THALASSEMIA; BLOOD SAMPLING; BONE DEMINERALIZATION; BONE DENSITY; CORRELATION ANALYSIS; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HORMONE BLOOD LEVEL; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; OSTEOPENIA; OSTEOPOROSIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PREDICTOR VARIABLE; PREVALENCE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; THALASSEMIA; THALASSEMIA MAJOR;

ABSORPTIOMETRY, PHOTON; ADOLESCENT; ADULT; BETA-THALASSEMIA; BONE DEMINERALIZATION, PATHOLOGIC; FEMALE; FEMUR; HAND BONES; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LUMBOSACRAL REGION; MALE; MIDDLE AGED; PREVALENCE; YOUNG ADULT;

EID: 47549105970     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2008.03191.x     Document Type: Article

References (46)

1. Vichinsky, E.P. (1990) The morbidity of bone disease in thalassemia. Annals of New York Academy of Sciences, 850, 344 348.
2. Domrongkitchaiporn, S., Sirikulchayanonta, V., Angchaisuksiri, P., Stitchantrakul, W., Kanokkantapong, C. Rajatanavin, R. (2003) Abnormalities in bone mineral density and bone histology in thalassemia. Journal of Bone and Mineral Research, 18, 1682 1688.
3. Cooley, T.B. Lee, P. (1925) A series of cases of splenomegaly in children with anemia and peculiar bone change. Tansaction of American Pediatric Society, 37 39.
4. Voskaridou, E. Terpos, E. (2004) New insights into the pathophysiology and management of osteoporosis in patients with β-thalassaemia. British Journal of Haematology, 127, 127 139.
5. Giardina, S.F.A., Reid, D.M., Scheneider, R., Lessere, M., Simmons, B., Rodriguez, A., Gertner, J., New, M. Hillgartner, M.W. (1995) Abnormal bone metabolism in thalassemia. Endocrine Disorders in Thalassemia, 39 46.
6. Jensen, C.E., Tuck, S.M., Agnew, J.E., Koneru, S., Morris, R.W., Yardumian, A., Prescott, E., Hoffbrand, A.V. Wonke, B. (1998) High prevalence of low bone mass in thalassemia major. British Journal of Haematology, 103, 911 915.
7. Karimi, M., Fotouhi Ghiam, A., Hashemi, A., Alinejad, S., Soweid, M. Kashef, S. (2007) Bone mineral density in β-thalassemia major and intermedia. Indian Pediatrics, 44, 29 32.
8. Perrotta, S., Cappellini, M.D., Bertoldo, F., Servedio, V., Iolascon, G., D'Agruma, L., Gasparini, P., Siciliani, M.C. Iolascon, A. (2000) Osteoporosis in β-thalassemia major patients: analysis of the genetic background. British Journal of Haematology, 111, 461 466.
9. Johanson, N.A. (1990) Musculoskeletal problems in hemoglobinopathy. Orthopedic Clinics of North America, 21, 191 198.
10. Di Stefano, M., Chiabotto, P., Roggia, C., Garofano, F., Lala, R., Piga, A. Isaia, G.C. (2004) Bone mass and metabolism in thalassemic children and adolescents treated with different iron-chelating drugs. Journal of Bone and Mineral Metabolism, 22, 53 57.
11. Pratelli, L., Verri, E., Fortini, M., Marconi, S., Zolezzi, C., Fornasari, P.M., Gamberini, M.R. De Sanctis, V. (2006) Chelation therapy and bone metabolism markers in thalassemia major. Journal of Pediatric Endocrinology and Metabolism, 19, 1335 1342.
12. Gamberini, M.R., Fortini, M., De Sanctis, V., Gilli, G. Testa, M.R. (2004) Diabetes mellitus and impaired glucose tolerance in thalassemia major. Incidence, prevalence, risk factors, and survival in patients followed in the Ferrara Center. Pediatric Endocrinology Reviews, 2 (Suppl. 2 285 291.
13. Chern, J.P., Lin, K.H., Tsai, W.Y., Wang, S.C., Lu, M.Y., Lin, D.T., Lin, K.S. Lo, S.H. (2003) Hypogonadotropic hypogonadism and hematologic phenotype in patients with transfusion-dependent β-thalassemia. Journal of Pediatric Hematology and Oncology, 25, 880 884.
14. Tiosano, D. Hochberg, Z. (2001) Endocrine complications of thalassemia. Journal of Endocrinological Investigation, 24, 716 723.
15. Angelopoulos, N.G., Goula, A., Rombopoulos, G., Kaltzidou, V., Katounda, E., Kaltsas, D. Tolis, G. (2006) Hypoparathyroidism in transfusion dependent patients with β-thalassemia. Journal of Bone and Mineral Metabolism, 24, 138 145.
16. Ohlsonn, C., Bengtsson, B., Isaksson, O.G.P., Andreassen, T.T. Slootweg, M.C. (1990) Growth hormone and bone. Endocrine Reviews, 19, 55 79.
17. Gotherstrom, G., Bengtsson, B.A., Bosaus, I., Johannsson, G. Svensson, J. (2007) Ten-year GH replacement increases bone mineral density in hypopituitary patients with adult onset GH deficiency. European Journal of Endocrinology, 156, 55 64.
18. Scacchi, M., Danesi, L., Cattaneo, A., Valassi, E., Pecori Girali, F., Argento, C., D'Angelo, E., Mirra, N., Carnelli, V., Zanaboni, L., Cappellini, D. Cavagnini, F. (2007) Prevalence of growth hormone deficiency in adult thalassaemic patients. Clinical Endocrinology, 67, 790 795.
19. Ghigo, E., Aimaretti, G., Gianotti, L., Bellone, J., Arvat, E. Camanni, F. (1996) New approach to the diagnosis of growth hormone deficiency in adults. European Journal of Endocrinology, 134, 352 356.
20. Brabant, G., von zur Mühlen, A., Wüster, C., Ranke, M.B., Kratzsch, J., Kiess, W., Ketelslegers, J.M., Wilhelmsen, L., Hulthen, L., Saller, B., Mattsson, A., Wilde, J., Schemer, R. Kann, P. On Behalf of the German KIMS Board (2003) Serum Insuline-like growth factor I reference values for an automated chemiluminescence immunoassay system: results from a multicenter study. Hormone Research, 60, 53 60.
21. Jonsson, K.B., Ljunghall, S., Karlstrom, O., Johansson, A.G., Mallmin, H. Ljunggren, O. (1993) Insulin-like growth factor I enhances the formation of type I collagen in hydrocortisone-treated human osteoblasts. Bioscience Reports, 13, 297 302.
22. Slootweg, M.C., Most, W.W., van Beek, E., Schot, L.P., Papapoulos, S.E. Lowik, C.W. (1992) Osteoclast formation together with interleukin-6 production in mouse long bones is increased by insulin-like growth factor-I. Journal of Endocrinology, 132, 433 438.
23. Hill, P.A., Reynolds, J.J. Meikle, M.C. (1995) Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function. Endocrinology, 135, 124 131.
24. Mohan, S., Jennings, J.C., Linkhart, T.A. Baylink, D.J. (1988) Primary structure of human skeletal growth factor: homology with human insulin-like growth factor-II. Biochemical Biophysica Acta, 966, 44 55.
25. Dresner Pollak, R., Rachmilewitz, E., Blumenfeld, A., Idelson, M. Goldfarb, A.W. (2000) Bone mineral metabolism in adults with β-Thalassaemia major and intermedia. British Journal of Haematology, 111, 902 907.
26. Lasco, A., Morabito, N., Gaudio, A., Crisafulli, A., Meo, A., Denuzzo, G. Frisina, N. (2002) Osteoporosis and β-thalassaemia major: role of the IGF-I/IGFBP-III axis. Journal of Endocrinological Investigation, 25, 338 344.
27. Murray, R.D., Adams, J.E. Shalet, S.M. (2006) A densitometric and morphometric analysis of the skeleton in adults with varying degrees of growth hormone deficiency. Journal of Clinical Endocrinology and Metabolism, 91, 432 438.
28. Kosowicz, J., El Ali, Z., Ziemnicka, K. Sowinski, J. (2007) Abnormalities in bone mineral distribution and bone scintigraphy in patients with childhood onset hypopituitarism. Journal of Clinical Densitometry, 10, 332 339.
29. Schlenker, R.A., Oltman, B.G. Kotek, T.J. (1976) Proceedings: Bone mineral mass and width in normal white women and men. American Journal of Roentgenology, 126, 1282 1283.
30. Snyder, P.J., Biller, B.M.K., Zagar, A., Jackson, I., Arafah, B.A., Nippoldt, T.B., Cook, D.M., Mooradian, A.D., Kwan, A., Scism-Bacon, J., Chipman, J.J. Hartman, M.L. (2007) Effect of growth hormone replacement on BMD, in adult-onset growth hormone deficiency. Journal of Bone and Mineral Research, 22, 762 770.
31. Sugimoto, T., Nishiyama, K., Kuribayashi, F. Chihara, K. (1997) Serum levels of insulin-like growth factor (IGF) I, IGF-binding protein (IGFBP) -2 and IGFBP-3 in osteoporotic patients with and without spinal fractures. Journal of Bone Mineral Research, 12, 1272 1279.
32. Muñoz-Torres, M., Mezquita-Raya, P., Lopez-Rodriguez, F., Torres-Vela, E., de Dios Luna, J. Escobar-Jimenez, F. (2001) The contribution of IGF-I to skeletal integrity in postmenopausal women. Clinical Endocrinology, 55, 759 766.
33. Seck, T., Scheidt-Nave, C., Leidig-Bruckner, G., Ziegler, R. Pfeilschiffer, J. (2001) Low serum concentrations of insulin-like growth factor I are associated with femoral bone loss in a population-based sample of postmenopausal women. Clinical Endocrinology, 55, 101 106.
34. Ljunghall, S., Johansson, A.G., Burman, P., Kampe, O., Lindh, E. Karlsson, F.A. (1992) Low plasma levels of insulin-like growth factor-1 (IGF-1) in male patients with idiopathic osteoporosis. Journal of Internal Medicine, 232, 59 64.
35. Kurland, E.S., Rosen, C.J., Cosman, F., McMahon, D., Chan, F., Shane, E., Lindsay, R., Dempster, D. Bilezikian, J.P. (1997) Insulin-like growth factor-I in men with idiopathic osteoporosis. Journal of Clinical Endocrinology and Metabolism, 82, 2792 2794.
36. Gillberg, P., Johansson, A.G., Blum, W.F., Groth, T. Ljunghall, S. (2001) Growth hormone secretion and sensitivity in men with idiopathic osteoporosis. Calcified Tissue International, 68, 67 73.
37. Murphy, M.G., Weiss, S., McClung, M., Schnitzer, T., Cerchio, K., Connor, J., Krupa, D. Gertz, B.J. (2001) Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women. Journal of Clinical Endocrinology and Metabolism, 86, 1116 1125.
38. Rosen, C.J. Bilezikian, J.P. (2001) Anabolic therapy for osteoporosis. Journal of Clinical Endocrinology and Metabolism, 86, 957 964.
39. Landin-Wilhelmsen, K., Nilsson, A., Bosacus, I. Bengtsson, B.A. (2003) Growth hormone increases bone mineral content in postmenopausal osteoporosis: a randomized placebo-controlled trial. Journal of Bone Mineral Research, 18, 406 409.
40. Chatterjee, R. Katz, M. (2000) Reversible hypogonadotrophic hypogonadism in sexually infantile male thalassaemic patients with transfusional iron overload. Clinical Endocrinology, 53, 33 42.
41. Caruso-Nicoletti, M., De Sanctis, V., Cavallo, L., Raiola, G., Ruggiero, L., Skordis, N. Wonke, B. (2001) International Workshop on Management of Puberty for Optimum Auxological Results. Management of puberty for optimal auxological results in beta-thalassaemia major. Journal of Pediatric Endocrinolgy and Metabolism, 14, 939 944.
42. Anapliotou, M.L., Kastanias, I.T., Psara, P., Evangelou, E.A., Liparaki, M. Dimittriou, P. (1995) The contribution of hypogonadism to the development of osteoporosis in thalassaemia major: new therapeutic approaches. Clinical Endocrinology, 42, 279 287.
43. De Sanctis, V., Savarino, L., Stea, S., Cervellati, M., Ciapetti, G., Tassinari, L. Pizzoferrato, A. (2000) Microstructural analysis of severe bone lesions in seven thalassemic patients treated with deferoxamine. Calcified Tissue International, 67, 128 133.
44. Chan, Y.L., Li, C.K., Pang, L.M. Chik, K.W. (2000) Desferrioxamine- induced long bone changes in thalassemic patients-radiographic features, prevalence and relations with growth. Clinical Radiology, 55, 610 614.
45. Mylona, M., Leotsinides, M., Alexandrides, T., Zoumbos, N. Dimopoulos, P.A. (2005) Comparison of DXA, QCT and trabecular structure in beta-thalassaemia. European Journal of Hematology, 74, 430 437.
46. Angelopoulos, N.G., Katounda, E., Rombopoulos, G., Goula, A., Kaltzidou, V., Kaltsas, D., Ioannis, P. Tolis, G. (2006) Evaluation of bone mineral density of the lumbar spine in patients with β-thalassaemia major with dual-energy x-ray absorptiometry and quantitative computed tomography: a comparison study. Journal of Pediatric Hematology and Oncology, 28, 73 78.